Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbations

Published:2017-02-08 Issue:2 Volume:12 Page:e0171229
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Sharma Ashutosh,Kirkpatrick Gordon,Chen Virginia,Skolnik Kate,Hollander Zsuzsanna,Wilcox Pearce,Quon Bradley S.

Funder

Cystic Fibrosis Canada

British Columbia Lung Association

University of British Columbia

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. 2013 Annual Data Report to the Center Directors,2014

2. Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials;D Bilton;Journal of cystic fibrosis: official journal of the European Cystic Fibrosis Society,2011

3. Quality of life in children and adolescents with cystic fibrosis: implications for optimizing treatments and clinical trial design;J Abbott;Paediatric drugs,2003

4. Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation;DB Sanders;American journal of respiratory and critical care medicine,2010

5. Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis;V Waters;Journal of cystic fibrosis: official journal of the European Cystic Fibrosis Society,2012

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting return of lung function after a pulmonary exacerbation using the cystic fibrosis respiratory symptom diary-chronic respiratory infection symptom scale;BMC Pulmonary Medicine;2024-07-24

2. Predicting return of lung function after a pulmonary exacerbation using the cystic fibrosis respiratory symptom diary-chronic respiratory infection symptom scale;2023-09-13

3. Acute Pulmonary Exacerbation Phenotypes in Patients with Cystic Fibrosis;Annals of the American Thoracic Society;2022-11

4. C-reactive protein (CRP) as a biomarker of pulmonary exacerbation presentation and treatment response;Journal of Cystic Fibrosis;2021-12

5. Duration of intravenous antibiotic treatment for acute exacerbations of cystic fibrosis: A systematic review;Journal of Cystic Fibrosis;2021-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3